Futura Medical PLC (AIM:FUM, OTC:FAMDF) has inked an exclusive licensing deal for its erectile dysfunction (ED) gel covering South Korea.
James Barder tells Katie Pilbeam that it's another 'brick in the wall' in building a 'network of distribution through the world' by teaming up with local subsidiary of Menarini Group, a large Italian biopharma business for this region.
South Korea is in the 'top 10' market for ED with an over 70 million people population.
Futura will support the effort to gain Korean marketing sign-off for MED3000, while its partner will be responsible for the costs associated with this push.